Linco-Sol 400 mg/g Powder for Use in Drinking Water for Pigs and Chickens

Medicated drinking water uptake can be affected by the severity of the disease. In case of
insufficient uptake of water, animals should be treated parenterally.
The susceptibility of
in vitro

Revised: July 2021
AN: 00290/2021 and 00292/2021
both . Where possible, therapy should be based on
local (regional, farm level) epidemiological information concerning the response of
enzootic pneumonia/necrotic enteritis to treatment with lincomycin.

Special precautions for use in animals
Use of the veterinary medicinal product preferably should be based on identification of the
target pathogen and susceptibility testing of the bacteria isolated from the animal.
However, also see text under section 4.4. Official, national and regional antimicrobial
policies should be taken into account when the veterinary medicinal product is used.
Use of the veterinary medicinal product deviating from the instructions given in the
summary of product characteristics may increase the prevalence of bacteria resistant to
the lincomycin and may decrease the effectiveness of treatment with other lincosamides,
macrolides and streptogramin B due to the potential for cross-resistance.
Repeated or prolonged use should be avoided by improving the farm management and
hygiene practices.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
This product contains lincomycin and lactose monohydrate, either of which can cause
allergic reactions in some people. People with known hypersensitivity to lincomycin or any
other lincosamide or to lactose monohydrate, should avoid contact with the veterinary
medicinal product.
Care should be taken not to raise and inhale any dust. The wearing of approved dust
masks (either a disposable half-mask respirator conforming to European Standard EN 149
or a non-disposable respirator to European Standard EN 140 with a filter to EN 143),
gloves and safety glasses are recommended whilst reconstituting or administering the
solution.
Direct contact of the product with the skin, eyes and mucous membranes should be
avoided.
In case of accidental exposure to the skin, eyes or mucous membranes, rinse abundantly
with water. In case of allergic reaction (inflammation of the face, lips or eyes or respiratory
difficulties) during reconstituting or administering of the product, seek medical advice
immediately and show the package leaflet or the label to the physician.
Do not smoke, eat or drink when handling the product.
Wash hands and any exposed skin with soap and water immediately after use.